Statement on new steps to progress agency’s continued analysis of prospective regulatory pathways for cannabis-made up of and cannabis-derived solutionsWhen a compound is authorised like a drug, the FDA ordinarily does not allow for it being sold in about-the-counter mainstream markets. However it’s currently getting used most often being a die